Over the past 12 years, dominant mutations in five distinct aaRS genes have been associated with CMT peripheral neuropathy, and significant progress has been made toward understanding how mutations in these ubiquitously expressed, essential enzymes may lead to selective degeneration of peripheral motor and sensory axons. The gene discussed is AARS1; the disease is peripheral neuropathy.